MJ

Mankaran Jit Singh Sodhi

Active Director Director DIN 10126623
DIN 10126623 First appointment Mar 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Mankaran Jit Singh Sodhi

Data last updated:

Mankaran Jit Singh Sodhi is a Director at Mindrug Biologics Private Limited (since 2025). The company operates in Healthcare.

DIN 10126623
Primary Designation Director
Industry Healthcare
First Appointment 24 Mar 2025
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mindrug Biologics Private Limited U24100PB2022PTC056582
Director24 Mar 20252022Active

Board colleagues of Mankaran Jit Singh Sodhi

Directorship timeline

Open interactive timeline →
Mindrug Biologics Private Limited
Premium access

Shareholding and investment profile for Mankaran Jit Singh Sodhi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mankaran Jit Singh Sodhi

Mankaran Jit Singh Sodhi currently holds 1 directorship: Mindrug Biologics Private Limited (Director, since 24 Mar 2025).

Mankaran Jit Singh Sodhi was first appointed on 24 Mar 2025 as Director at Mindrug Biologics Private Limited.

The current boards of Mankaran Jit Singh Sodhi's companies include Gurkaranjit Singh Sodhi (Mindrug Biologics Private Limited), Kulpreet Kaur Sodhi (Mindrug Biologics Private Limited), Swaranjit Singh Sodhi (Mindrug Biologics Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available